tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MNKD Stock Latest News

MannKind price target lowered to $8 from $10 at RBC Capital
The FlyMannKind price target lowered to $8 from $10 at RBC Capital
3d ago
MNKD
MannKind assumed with a Buy at H.C. Wainwright
PremiumThe Fly
MannKind assumed with a Buy at H.C. Wainwright
10d ago
MNKD
MannKind’s Afrezza: A Promising Undervalued Opportunity in Diabetes Treatment
PremiumRatings
MannKind’s Afrezza: A Promising Undervalued Opportunity in Diabetes Treatment
29d ago
MNKD
MannKind’s Growth Potential and Strategic Positioning Amidst Near-Term Uncertainties: A Buy Rating by Faisal Khurshid
PremiumRatings
MannKind’s Growth Potential and Strategic Positioning Amidst Near-Term Uncertainties: A Buy Rating by Faisal Khurshid
1M ago
MNKD
MannKind’s Afrezza: A Significantly Undervalued Investment Opportunity with Promising Clinical Data
PremiumRatings
MannKind’s Afrezza: A Significantly Undervalued Investment Opportunity with Promising Clinical Data
1M ago
MNKD
MannKind’s Strategic Growth Potential and Market Positioning: A Buy Recommendation
PremiumRatingsMannKind’s Strategic Growth Potential and Market Positioning: A Buy Recommendation
2M ago
MNKD
MannKind Stockholders Approve Board and Compensation
Premium
Company Announcements
MannKind Stockholders Approve Board and Compensation
2M ago
8K
MNKD
MannKind Announces CMO Transition and Separation Agreement
Premium
Company Announcements
MannKind Announces CMO Transition and Separation Agreement
2M ago
8K
MNKD
Promising Clinical Data and Market Potential Drive Buy Rating for MannKind’s Afrezza
PremiumRatings
Promising Clinical Data and Market Potential Drive Buy Rating for MannKind’s Afrezza
2M ago
MNKD
MannKind’s Strong Financial Performance and Promising Pipeline Drive Buy Rating
PremiumRatings
MannKind’s Strong Financial Performance and Promising Pipeline Drive Buy Rating
3M ago
MNKD
MannKind Corporation Reports Strong Q1 2025 Results
PremiumCompany Announcements
MannKind Corporation Reports Strong Q1 2025 Results
3M ago
MNKD
MannKind’s Promising Growth and Strategic Advancements Justify Buy Rating
PremiumRatings
MannKind’s Promising Growth and Strategic Advancements Justify Buy Rating
3M ago
MNKD
MannKind Corporation’s Earnings Call: Optimistic Outlook Amid Challenges
PremiumCompany AnnouncementsMannKind Corporation’s Earnings Call: Optimistic Outlook Amid Challenges
3M ago
MNKD
MannKind’s Promising Growth Potential: Buy Rating Backed by Strong Financials and Strategic Advancements
Premium
Ratings
MannKind’s Promising Growth Potential: Buy Rating Backed by Strong Financials and Strategic Advancements
3M ago
MNKD
MannKind reports Q1 EPS 7c vs 6c last year
Premium
The Fly
MannKind reports Q1 EPS 7c vs 6c last year
3M ago
MNKD
MannKind Corporation (MNKD) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
MannKind Corporation (MNKD) Q1 Earnings Cheat Sheet
3M ago
MNKD
Strong Revenue Growth and Market Expansion Drive Buy Rating for MannKind
PremiumRatings
Strong Revenue Growth and Market Expansion Drive Buy Rating for MannKind
3M ago
MNKD
Mizuho starts MannKind with Outperform on positive Tyvaso checks
PremiumThe Fly
Mizuho starts MannKind with Outperform on positive Tyvaso checks
4M ago
MNKD
MannKind initiated with an Outperform at Mizuho
PremiumThe Fly
MannKind initiated with an Outperform at Mizuho
4M ago
MNKD
MannKind management to meet with Cantor Fitzgerald
PremiumThe FlyMannKind management to meet with Cantor Fitzgerald
4M ago
MNKD
MannKind’s Earnings Call Highlights Robust Growth and Strategic Success
Premium
Company Announcements
MannKind’s Earnings Call Highlights Robust Growth and Strategic Success
5M ago
MNKD
MannKind Corporation Reports Strong 2024 Financial Growth
Premium
Company Announcements
MannKind Corporation Reports Strong 2024 Financial Growth
5M ago
MNKD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >